News brief
On August 6, 2026, per Labiotech, natural product drug discovery company LifeMine Therapeutics raised $188M in a Series E. Industry coverage in September 2026 noted an additional ~$75M Series D during August; the two rounds should not be combined into a single figure. Details are subject to company announcements.
Connected profiles
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- www.labiotech.eu ↗Published Aug 6, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年8月6日，据Labiotech报道，天然产物药物发现公司LifeMine Therapeutics完成1.88亿美元E轮融资。2026年9月行业报道指出，8月期间公司另有约7500万美元D轮融资，两笔属于不同轮次口径。相关轮次详情需优先核对公司公告。